Wii Balance Board in Dizziness

This study has been withdrawn prior to enrollment.
(The study never started since it did not receive IRB approval)
Sponsor:
Information provided by (Responsible Party):
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT01345422
First received: April 28, 2011
Last updated: December 7, 2015
Last verified: December 2015
  Purpose
Patients with dizziness presently undergo physical therapy rehabilitation. Our study will study whether Wii Balance Board made by Nintendo Inc. will be helpful in patients with dizziness. They will undergo dizziness evaluation to quantify their dizziness.

Condition Intervention
Dizziness
Other: Wii Balance Board

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: A Pilot Study to Assess the Usefulness of the Wii Balance Board for Dizziness

Resource links provided by NLM:


Further study details as provided by Kaiser Permanente:

Enrollment: 0
Arms Assigned Interventions
Experimental: Wii Balance Board
Wii Balance Board Training
Other: Wii Balance Board
Participant will undergo Nintendo Wii Balance Board training for two months , five days a week for 30 minutes

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Abnormal posturography exam

Exclusion Criteria:

  • Pregnant Women and children
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01345422

Sponsors and Collaborators
Kaiser Permanente
Investigators
Principal Investigator: David Cheng, MD Southern California Permanente Medical Group
  More Information

Responsible Party: Kaiser Permanente
ClinicalTrials.gov Identifier: NCT01345422     History of Changes
Other Study ID Numbers: HNS1 
Study First Received: April 28, 2011
Last Updated: December 7, 2015
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Dizziness
Vertigo
Ear Diseases
Labyrinth Diseases
Nervous System Diseases
Neurologic Manifestations
Otorhinolaryngologic Diseases
Sensation Disorders
Signs and Symptoms
Vestibular Diseases

ClinicalTrials.gov processed this record on May 03, 2016